Dr. Hung-Chin Tsai is the Principal Investigator of UB-421’s cART substitution, phase III clinical trial in Taiwan. He currently serves as the Director of Infection Control Unit of Kaohsiung Veteran General Hospital, an Attending Physician at the Infection Disease Division of Kaohsiung Veteran General Hospital, and an Associate Professor of Internal Medicine at the Department of Medicine, National Yang-Ming University.
From 1999 to 2001, he completed all his medical training at Kaohsiung Veteran General Hospital from a resident to an attending physician at the Internal Medicine and Infectious Disease Division. Dr. Tsai has authored and co-authored over 90 papers in scientific journals.
Dr. Tsai holds an M.D. from Kaohsiung Medical University, School of Medicine and received his Ph.D. from Kaohsiung Medical University Medical Research Institute in 2007.